Much advice has appeared in the media over the past two months about how to manage anxiety, depression and other mental health challenges during the coronavirus pandemic.
Plenty of speculation, particularly on social media, has accompanied it: Will suicide rates increase? Will adolescent suicide rates decline with increased supervision? Will prescriptions for antidepressants rise? Will this trend revolutionize telemedicine in mental health? Continue reading
In early October, the U.S. Food and Drug Administration approved Paratek Pharmaceuticals’ new antibiotic Nuzyra, which kills bacteria associated with skin and lung infections.
The approval was notable because there are so few new antibiotics coming onto the market, , says journalist Maryn McKenna in Wired magazine, largely because most drug companies don’t think antibiotics — which have wiped out the threat of many infectious diseases — to be worth the investment.
The problem is a unique business and policy dilemma for society. Continue reading
The back-to-school season brings anxious anticipation and excitement for many, but also another look at bullying by public health professionals, policy makers, parents and educators.
Attention to the issue has grown in recent years as awareness has grown about the issue both online and in schools and communities. It’s even become a topic in the 2016 presidential election. Continue reading